For our PhDs in Focus blog series, Zelpha D'Souza outlines how their Manchester BRC PhD project is investigating how to improve clinical trials in rare conditions, as part of the Rare Conditions theme.
Almost half of all UK adults regularly take prescription medicines and the annual NHS budget for medicines is approximately £17.4 billion per year, with over 1.1 billion items prescribed annually.
For our PhDs in Focus blog series, Aoife O’Sullivan outlines how their Manchester BRC PhD project is investigating how certain rare developmental genetic conditions affect a person’s thinking, behavioural, emotional and social skills, as part of the Rare Conditions theme.
The Academy of Medical Science has elected Professor Bill Newman, Manchester BRC Rare Conditions Co-Theme Lead, to its prestigious Fellowship, in recognition of his many achievements and outstanding contributions to research in pharmacogenetics and rare conditions.
Two Manchester BRC supported research teams have been recognised at The University of Manchester's Making a Difference Awards.
Researchers are addressing health conditions that affect many people, but which traditionally have had less research undertaken, through our Under-Researched Conditions Cluster. Find out more about the impact of our cutting-edge research in the second film of our Spotlight On series.
A new platform has been announced, bringing together UK strengths in rare diseases research to improve diagnosis and treatment.
University of Manchester Chancellor Nazir Afzal OBE has become the 1,000th person in Greater Manchester to take part in a huge research project seeking to help improve health outcomes for South Asian people.